메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Xinhua Silk Road: Annual wine-themed folk culture festival held in E. China's Jiangxi Province

BEIJING, Dec. 17, 2025 -- A wine-themed folk culture festival kicked off in Mengshan Town in east China's Jiangxi Province on Dec. 4, offering visitors an immersive experience of local culture, wine and cuisine. On the event, visitors were invited to join many interactive experience activities including ring toss game, making Maci, a glutinous rice cake, calligraphy writing, breaking wine bowls, Touhu game, a game in which the winner is decided by the number of arrows thrown into a distant pot, and a wine competition. The event, already been celebrated for six sessions,
- 김장윤(JASON KIM) 기자
- 2025-12-17 09:22
Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma

SHANGHAI and HONG KONG, Dec. 17, 2025 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the Malaysian National Pharmaceutical Regulatory Agency has approved a supplemental New Drug Application (sNDA) for XPOVIO® (selinexor) for the treatment of adult patients with relapsed or refractory diffuse l
- 김갑성 기자
- 2025-12-17 09:00
Robotware.ai Advances AI Poultry Disease Detection PoC in Malaysia with SDEC

KUALA LUMPUR, Malaysia, Dec. 17, 2025 -- Robotware.ai , a Korea-based artificial intelligence company specializing in livestock intelligence solutions, is advancing its proof-of-concept (PoC) deployment in Malaysia in collaboration with Sarawak Digital Economy Corporation (SDEC) , following the successful implementation of its system at local poultry farms. The ongoing PoC is focused on validating the real-world performance of Robotware.ai's AI-powered poultry disease detection technology under live farm operating conditions. The initiative aligns with Malaysia's efforts to moderniz
- 황정호 기자
- 2025-12-17 09:00
SHOPLINE Received MPI Licence in Singapore, Strengthening Regional and Global Payments

SINGAPORE, Dec. 17, 2025 -- Instage Technology Pte. Ltd., a subsidiary of SHOPLINE, a leading global commerce Software-as-a-Service (SaaS) platform, today announced that it has obtained the Major Payment Institution (MPI) licence issued by the Monetary Authority of Singapore (MAS). The licence covers five regulated payment services — Account Issuance Service, Domestic Money Transfer Service, Cross-Border Money Transfer Service, Merchant Acquisition Service, and E-Money Issuance Service — enabling SHOPLINE to further strengthen comprehensive payment solutions for over 600,000 merchants
- 황정호 기자
- 2025-12-17 09:00
SHOPLINE Received MPI Licence in Singapore, Strengthening Regional and Global Payments

SINGAPORE, Dec. 17, 2025 -- Instage Technology Pte. Ltd., a subsidiary of SHOPLINE, a leading global commerce Software-as-a-Service (SaaS) platform, today announced that it has obtained the Major Payment Institution (MPI) licence issued by the Monetary Authority of Singapore (MAS). The licence covers five regulated payment services — Account Issuance Service, Domestic Money Transfer Service, Cross-Border Money Transfer Service, Merchant Acquisition Service, and E-Money Issuance Service — enabling SHOPLINE to further strengthen comprehensive payment solutions for over 600,000 merchants
- 황정호 기자
- 2025-12-17 09:00
Global Times: 'Kunlun,' a common emotional anchor, spiritual refuge, and homeland for the Chinese nation

BEIJING, Dec. 17, 2025 -- Editor's Note: Perched on the Qinghai-Xizang Plateau, a stone has captivated scholars by reshaping the narrative of early Chinese history. The Garitang Keshi, which can be translated as "Garitang Engraved Stone," has been identified as an authentic relic of the Qin Dynasty (221BC-206BC). It records an imperial mission by Emperor Qinshihuang, who unified China for the first time, to seek the elixir of life from the mythical Kunlun Mountains. Scholars highlight the stone as a geographic anchor that places the legendary "Kunlun" near the sourc
- 김장윤(JASON KIM) 기자
- 2025-12-17 08:49
ICAC Commissioner attends international anti-graft conference online while staying in Hong Kong to oversee corruption investigation

HONG KONG, Dec. 17, 2025 -- ICAC Commissioner Woo Ying-ming, in his capacity of President of the International Association of Anti-Corruption Authorities (IAACA), earlier attended the IAACA Annual Conference held in Doha, Qatar and delivered an opening remarks through video conferencing. Mr Woo was going to head a delegation to Doha to chair the IAACA Executive Committee meeting, attend the IAACA Annual Conference and host bilateral meetings with heads of anti-corruption agencies (ACAs) between December 12 and 14. In light of the fire at Wang Fuk Court in Tai Po, Mr Woo decided
- 황정호 기자
- 2025-12-17 08:45
Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

ADELAIDE, Australia, Dec. 17, 2025 -- Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence following surgery. Ferronova's super-paramagnetic iron oxide nanoparticles bind to cells found in lymph nodes which aim to enable identification of tissue that could contain cancerous cells. The technology aims to support more informed surgical decision-making and address the problem that cancer cells are oft
- 김갑성 기자
- 2025-12-17 08:30
Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies

SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, Dec. 17, 2025 -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generation multi-specific antibodies. Under the terms of the agreement, Harbour BioMed will collaborate with Bristol Myers Squibb to advance and accelerate multi-specific antibody discovery pro
- 김갑성 기자
- 2025-12-17 08:04
Jiaying Pharmaceutical: A New Pathway for the Industrialization of Century-Old Hakka Medicine

HONG KONG, Dec. 17, 2025 -- Recently, Meizhou in Guangdong, known as the "World Capital of the Hakka", welcomed a globally watched event, the Seventh World Hakka Entrepreneurs Convention. At this gathering that drew the attention of Hakka entrepreneurs worldwide, Guangdong Jiaying Pharmaceutical Co., Ltd. made a brilliant appearance with its star products, including Double-ingredient Throat Wind Relief Powder, Solid Essence Ginseng and Antler Pill, and Borneol Ointment, showcasing to the world the unique charm of Hakka medicine. Amid the wave of globalization, traditional Chi
- 김갑성 기자
- 2025-12-17 08:00

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2026-01-12_MON

2026-01-11_SUN

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 12일 09시 40분